|
| Scientists developed synthetic notch (synNotch)–CAR T cells targeting solid tumor antigens and used them to treat mouse models of mesothelioma, ovarian cancer, and glioblastoma. [Science Translational Medicine] |
|
|
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers showed that optogenetic activation of parvalbumin-positive cells in the medial septal area enabled selective pacing of local field potential oscillations in medial entorhinal cortex. [Science Advances] |
|
|
|
| Scientists developed a bioinformatics pipeline, centered on transcription factors co-occupancy of regulatory DNA, and used it to predict factors that potentiate the effects of pro-regenerative Klf6 in vitro. [Nature Communications] |
|
|
|
| In patient-derived glioblastoma neurospheres, EGF induced TAZ through EGFR-ERK and EGFR-STAT3 signaling, and the constitutively active EGFRvIII mutation caused EGF-independent hyperactivation of TAZ. [Cancer Research] |
|
|
|
| Investigators demonstrated that Patch-seq technology can be applied both to better understand molecular mechanisms underlying a complex neurological disease at the single-cell level and to provide a platform for screening for therapeutics for the disease. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Researchers showed that in mouse hippocampal neurons, dense core vesicles fusion was strongly and equally reduced in synaptotagmin-1 (Syt1)- or Syt7-deficient neurons, but combined Syt1/Syt7 deficiency did not reduce fusion further. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Researchers identified that the highly expressed POU Class Homeobox 2 (POU2F2) significantly correlated with poor prognosis of glioblastoma patients. POU2F2 promoted cell proliferation and regulated glycolytic reprogramming. [Cell Death & Disease] |
|
|
|
| Transient overexpression of miR-138 in glioblastoma cells inhibited cell proliferation, cell cycle, migration, and wound healing capability. The authors unveiled that miR-138 negatively regulated the expression of CD44 by directly binding to the 3′ UTR of CD44. [Scientific Reports] |
|
|
|
| To improve treatment of glioblastoma, including those resistant to temozolomide , researchers explored the potential of targeting dopamine receptor signaling. [PLoS One] |
| |
|
|
|
| Scientists provide an overview of the diverse roles of non-neuronal cells in relation to the pathogenesis of ALS and the emerging potential of non-neuronal cell biomarkers to advance therapeutic development. [Nature Reviews Neurology] |
|
|
|
| The authors examine the roles microglia play in cerebellar function, development, and aging. The emerging findings on cerebellar microglia may also provide insights into disease processes involving cerebellar dysfunction. [Trends in Neurosciences] |
|
|
|
|
| The first patients in the United States have been treated with Rapid Medical’s FDA cleared TIGERTRIEVER™ revascularization device by Dr. Rishi Gutpa, Director of Neurocritcal Care at Wellstar Health System in Georgia. TIGERTRIEVER is the first adjustable stent retriever, enabling neuro interventionalists to better remove blood clots and restore blood flow to the brain following an ischemic event—a condition that devastates 800,000 Americans annually. [Rapic Medical, Inc. (Business Wire, Inc.)] |
|
|
|
|
| June 14 – 18, 2021 Virtual |
|
|
|
|
|
| St. Jude Children’s Research Hospital – Memphis, Tennessee, United States |
|
|
|
| Deep Genomics, Inc. – Toronto, Ontario, Canada |
|
|
|
| Cyprus Cancer Research Institute – Republic of Cyprus |
|
|
|
| Max Planck Institute – Nijmegen, Netherlands |
|
|
|
| University of British Columbia – Vancouver, British Columbia, Canada |
|
|
|
|